Study of immune cell markers in people with lupus
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This study looks at how certain immune cells (natural killer T cells) behave in people with systemic lupus, by measuring specific immune receptor markers in blood. It may help researchers better understand lupus and how it can connect with other conditions like antiphospholipid syndrome or Sjögren’s.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a definite diagnosis of systemic lupus
- Your lupus can be newly diagnosed or you are in a relapse
- Your healthcare team feels your condition is stable enough for participation
- You need to have blood drawn for follow-up as part of the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune cells in people with certain autoimmune diseases or immune deficiencies. The goal is to understand how these cells work, which may help improve future treatments.
This study looks at a type of immune cell in patients with active lupus. It may help doctors understand how lupus affects the immune system and could lead to better treatments.
This study looks for certain immune markers (HLA antibodies) in stored blood samples from people with lupus. It may help doctors understand how the immune system behaves in lupus.
This study aims to see if a blood test that measures a specific protein-related molecule can help doctors know how active your lupus is. If successful, this could lead to a simpler way to monitor the disease and adjust treatment.
This study looks at a specific type of immune cell activity (called neutrophil extracellular traps) in the blood of people with systemic sclerosis, other connective tissue diseases, and healthy volunteers. It aims to understand how these cells may be involved in the disease and could lead to better treatments.
This study looks at whether two blood test markers (called T IgG and T IgM) can help doctors understand how active your lupus is and how much damage the disease has caused. If you join, your blood will be tested, and the results may help guide your treatment.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.